|LY333328 二磷酸盐|CsnPharm

CAS No.: 192564-14-0

Oritavancin diphosphate/奥利万星二磷酸盐 Catalog No. CSN18067

Synonyms: LY333328 diphosphate;Oritavancin (phosphate);LY-333328

Oritavancin diphosphate is a semisynthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive bacterial infections.

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

加入收藏

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

实验方案

技术信息

生物活性

描述Oritavancin diphosphate is a semisynthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive bacterial infections.
临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT01252732	Wound Infection ... more >> Abscess Systemic Inflammation Cellulitis Collapse <<	Phase 3	Completed	-	United States, California ... more >> Sharp Grossmont Hospital La Mesa, California, United States, 91942 Collapse <<
NCT01762839	Healthy	Phase 1	Completed	-	United States, Wisconsin ... more >> Spaulding Clinical West Bend, Wisconsin, United States, 53095 Collapse <<
NCT02340988	Healthy	Phase 1	Completed	-	United States, Wisconsin ... more >> Spaulding Clinical West Bend, Wisconsin, United States, 53095 Collapse <<

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 0.5027 mL
- 2.5137 mL
- 5.0274 mL
- 5 mM
- 0.1005 mL
- 0.5027 mL
- 1.0055 mL
- 10 mM
- 0.0503 mL
- 0.2514 mL
- 0.5027 mL

技术信息

CAS号

192564-14-0

储存条件

粉末: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C

液体: -20°C:3-6 月 -80°C:12月

分子式

C86H103Cl3N10O34P2

运输

蓝冰

分子量

1989.09

别名

LY333328 diphosphate;Oritavancin (phosphate);LY-333328;Oritavancin;brand name: Orbactiv;奥利万星二磷酸盐

溶解度

DMSO	40.0 mg/mL (20.1 mM) warming

动物实验配方

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT01252732	Wound Infection ... more >> Abscess Systemic Inflammation Cellulitis Collapse <<	Phase 3	Completed	-	United States, California ... more >> Sharp Grossmont Hospital La Mesa, California, United States, 91942 Collapse <<
NCT01762839	Healthy	Phase 1	Completed	-	United States, Wisconsin ... more >> Spaulding Clinical West Bend, Wisconsin, United States, 53095 Collapse <<
NCT02340988	Healthy	Phase 1	Completed	-	United States, Wisconsin ... more >> Spaulding Clinical West Bend, Wisconsin, United States, 53095 Collapse <<
NCT02134301	Gram Positive Bacterial Infect... more >>ions Collapse <<	Phase 1	Recruiting	June 2019	United States, Arkansas ... more >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Robin Gibson, RN 501-364-1542 gibsonrobina@uams.edu Principal Investigator: Jose R Romero, MD United States, California CHOC Children's Recruiting Orange, California, United States, 92868 Contact: Claudia Enriquez 714-509-4791 cenriquez@CHOC.ORG Principal Investigator: Antonio Arrieta, MD Rady Children's Hospital San Diego Recruiting San Diego, California, United States, 92123 Contact: Sara Hingtgen, RN, MSN 858-966-8450 shingtgen@rchsd.org Contact: Mike Farrell, RN, BSN 858-966-8450 mfarrell@rchsd.org Principal Investigator: John Bradley, MD Harbour-UCLA Medcial Center Completed Torrance, California, United States, 90509 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Recruiting Louisville, Kentucky, United States, 40202 Principal Investigator: Claudia Espinosa, MD United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Jenny Goodwin 402-559-0681 jennifer.goodwin@unmc.edu Principal Investigator: Kari A Simonsen, MD United States, New York Stony Brook University Medical Center Withdrawn Stony Brook, New York, United States, 11794 United States, Ohio Rainbow Babies and Children's Hospital Completed Cleveland, Ohio, United States, 44106 Toledo Children's Hospital Terminated Toledo, Ohio, United States, 43606 Collapse <<
NCT01784536	Healthy	Phase 1	Completed	-	United States, Wisconsin ... more >> Spaulding Clinical West Bend, Wisconsin, United States, 53095 Collapse <<
NCT01252719	Wound Infection ... more >> Abscess Systemic Inflammation Cellulitis Collapse <<	Phase 3	Completed	-	United States, California ... more >> Sharp Chula Vista Medical Center Chula Vista, California, United States, 91911 Collapse <<

Oritavancin diphosphate/奥利万星二磷酸盐 Catalog No. CSN18067

靶点选择性

请登录您的专属账户

确认信息